Case series of outcome of newborn babies exposed to Lassa fever virus infection

Submitted: 14 July 2020
Accepted: 18 September 2020
Published: 21 October 2020
Abstract Views: 587
PDF: 264
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Lassa fever (LF) is an acute viral hemorrhagic fever caused by the Lassa virus, a zoonotic infection transmitted by the infected multimammate mouse which is endemic in West African countries. It affects all ages contributing to high maternal and neonatal mortality rates. Neonates are at risk of vertical and horizontal transmission of Lassa virus. We report a series of six newborns, three of whom were delivered to Lassa fever positive mothers and were managed as exposed babies while the remaining three were diagnosed with neonatal Lassa fever. None of the babies exposed to the virus became infected and two of these exposed babies had a positive outcome. All the babies with neonatal Lassa fever died days after birth even before confirming the diagnosis and initiating ribavirin treatment. This highlights the need for prompt diagnosis in utero with treatment of mother before delivery to improve the neonatal outcome. Also, the need to commence intravenous ribavirin treatment in highly suspicious cases of neonatal Lassa fever while awaiting confirmation of the diagnosis is emphasized.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West African sub-region: An overview. J Vector Borne Dis 2007;44:1–11.
Frame JD, Baldwin JM, Gocke D. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 1970;19:670–6. DOI: https://doi.org/10.4269/ajtmh.1970.19.670
Fisher-Hoch SP, McCormick JB. Lassa fever vaccine: A review. Expert Rev Vaccines 2004;3:103–11.
McCormick JB, King IJ, Webb PA, et al. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 1987;155:445–55. DOI: https://doi.org/10.1093/infdis/155.3.445
World Health Organization. WHO Lassa Fever sheet. 2017. Accessed: 2020 Apr 13. Available from: https://www.who.int/csr/don/28-june-2017-lassa-fever-nigeria/en/.
Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospectively study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br Med J 1988;284:584–7. DOI: https://doi.org/10.1136/bmj.297.6648.584
Branco LM, Boisen ML, Andersen KG, et al. Lassa hemorrhagic fever in a late term pregnancy from northern sierra leone with a positive maternal outcome: case report. Virol J 2011;404. DOI: https://doi.org/10.1186/1743-422X-8-404
Ajayi NA, Ukwaja KN, Ifebunandu NA, et al. Lassa fever – full recovery without ribavarin treatment: a case report. Afr Health Sci 2014;14:1074–7. DOI: https://doi.org/10.4314/ahs.v14i4.40
Stadhouders R, Pas SD, Anber J, et al. The Effect of Primer-Template Mismatches on the Detection and Quantification of Nucleic Acids Using the 5’ Nuclease Assay. J Mol Diagnostics 2010;12:109–17. DOI: https://doi.org/10.2353/jmoldx.2010.090035
Chan GJ, Lee AC, Baqui AH, et al. Prevalence of early-onset neonatal infection among newborns of mothers with bacterial infection or colonization: a systematic review and meta-analysis. BMC Infect Dis Dis 2015;15:813. doi:10.1186/s12879-015-0813-3. DOI: https://doi.org/10.1186/s12879-015-0813-3
Eze KC, Salami TA, Kpolugbo JU. Acute abdominal pain in patients with lassa fever: Radiological assessment and diagnostic challenges. Niger Med J 2014;55:195–200. DOI: https://doi.org/10.4103/0300-1652.132037
Adewuyi GM, Fowotade A, Adewuyi BT. Lassa fever: another infectious menace. African J Clin Exp Microbiol 2009;10:144-55. DOI: https://doi.org/10.4314/ajcem.v10i3.43407
Monso MH, Cole AK, Frame JD, et al. Pediatric Lassa fever: A review of 33 Liberian cases. Am J Trop Med Hyg 1987;36:408–15. DOI: https://doi.org/10.4269/ajtmh.1987.36.408
Monath TP, Mertens PE, Patton R, et al. A hospital epidemic of Lassa fever in Zorzor, Liberia. Am J Trop Med Hyg 1972;22:773–9. DOI: https://doi.org/10.4269/ajtmh.1973.22.773
Nasir IA, Sani FM. Outbreaks, pathogen containment and laboratory investigations of Lassa fever in Nigeria: how prepared are we? Int J Trop Dis Heal 2015;10:1–10. DOI: https://doi.org/10.9734/IJTDH/2015/19391
Centers for Disease Control and Prevention (CDC) Lassa Fever, CDC fact sheet, CDC, June, 2014. Available from: http://www.cdc.gov/vhf/ lassa/.
Olschläger S, Lelke M, Emmerich P, et al. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5’ region of S RNA. J Clin Microbiol 2010;48:2009–13. DOI: https://doi.org/10.1128/JCM.02351-09
Richmond JK, Baglole DJ. Lassa fever epidemiology, clinical features, and social consequences. Br Med J 2003;327:1271–5. DOI: https://doi.org/10.1136/bmj.327.7426.1271

How to Cite

Obu, D. C., Ezeanosike, O. B., & Nwukor, S. A. . . (2020). Case series of outcome of newborn babies exposed to Lassa fever virus infection. Annals of Clinical and Biomedical Research, 1(1). https://doi.org/10.4081/acbr.2020.97